My research centers on vaccine development, translational medicine, and disease genetics. A major focus of my work is immunoinformatics-driven design of multi-epitope vaccines against viral pathogens, including dengue and monkeypox viruses, combining computational approaches with wet-lab techniques such as recombinant protein expression, purification, and immunological validation to develop cost-effective, pan-serotype vaccine candidates. I am also engaged in antiviral drug discovery, including the identification of natural compound inhibitors against emerging viruses such as Nipah virus, and in genetic association studies examining the role of genetic variants in disease susceptibility, including breast cancer and lung cancer in the Bangladeshi population. Together, these interests reflect my broader aim of bridging computational and experimental approaches to advance translational research in infectious disease and human genetics.

Associated Sustainable Development Goals (SDGs):

SDG 3: Good Health and Well-being

• Target 3.3: End epidemics of AIDS, tuberculosis, malaria, and neglected tropical diseases, and combat hepatitis and other communicable diseases.
• Target 3.4: Reduce premature mortality from non-communicable diseases (NCDs).
• Target 3.b: Support research and development of vaccines and medicines for communicable and non-communicable diseases that primarily affect developing countries.

SDG 9: Industry, Innovation and Infrastructure

• Target 9.5: Enhance scientific research and upgrade technological capabilities, including through R